Group One Trading’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-278,300
Closed -$8.25M 8259
2023
Q4
$8.25M Sell
278,300
-135,000
-33% -$2.69M 0.02% 808
2023
Q3
$6.56M Buy
413,300
+200,400
+94% +$3.33M 0.02% 767
2023
Q2
$4.02M Buy
212,900
+39,400
+23% +$465K 0.01% 1137
2023
Q1
$666K Buy
173,500
+163,500
+1,635% +$697K ﹤0.01% 2492
2022
Q4
$49.6K Sell
10,000
-26,300
-72% -$143K ﹤0.01% 4998
2022
Q3
$174K Buy
36,300
+10,400
+40% +$54.8K ﹤0.01% 4278
2022
Q2
$117K Buy
25,900
+6,100
+31% +$26.5K ﹤0.01% 4834
2022
Q1
$94K Buy
19,800
+4,200
+27% +$23.3K ﹤0.01% 5554
2021
Q4
$116K Sell
15,600
-4,800
-24% -$29.8K ﹤0.01% 5604
2021
Q3
$116K Buy
20,400
+15,800
+343% +$91.3K ﹤0.01% 5765
2021
Q2
$30K Buy
4,600
+1,600
+53% +$11.2K ﹤0.01% 6963
2021
Q1
$24K Sell
3,000
-149,100
-98% -$1.22M ﹤0.01% 6687
2020
Q4
$981K Buy
152,100
+149,700
+6,238% +$873K ﹤0.01% 2658
2020
Q3
$9K Sell
2,400
-24,800
-91% -$100K ﹤0.01% 5476
2020
Q2
$125K Buy
27,200
+11,700
+75% +$49.8K ﹤0.01% 3740
2020
Q1
$53K Buy
15,500
+2,800
+22% +$12.2K ﹤0.01% 3678
2019
Q4
$65K Buy
12,700
+6,900
+119% +$23.4K ﹤0.01% 3888
2019
Q3
$14K Sell
5,800
-80,900
-93% -$215K ﹤0.01% 4493
2019
Q2
$188K Sell
86,700
-213,200
-71% -$504K ﹤0.01% 2901
2019
Q1
$813K Buy
299,900
+219,300
+272% +$950K 0.01% 1557
2018
Q4
$387K Buy
80,600
+69,300
+613% +$421K ﹤0.01% 2167
2018
Q3
$107K Sell
11,300
-195,600
-95% -$1.88M ﹤0.01% 3488
2018
Q2
$2.01M Buy
206,900
+27,000
+15% +$285K 0.02% 1127
2018
Q1
$1.89M Buy
179,900
+173,900
+2,898% +$1.72M 0.02% 1042
2017
Q4
$38K Sell
6,000
-140,000
-96% -$863K ﹤0.01% 3870
2017
Q3
$1.12M Buy
146,000
+109,000
+295% +$724K 0.01% 1478
2017
Q2
$263K Sell
37,000
-18,600
-33% -$85.1K ﹤0.01% 2443
2017
Q1
$215K Sell
55,600
-89,300
-62% -$261K ﹤0.01% 2479
2016
Q4
$296K Buy
144,900
+22,200
+18% +$44.6K ﹤0.01% 2141
2016
Q3
$329K Buy
122,700
+97,000
+377% +$282K ﹤0.01% 2130
2016
Q2
$79K Buy
25,700
+20,400
+385% +$128K ﹤0.01% 3026
2016
Q1
$45K Sell
5,300
-11,100
-68% -$93.9K ﹤0.01% 3315
2015
Q4
$223K Sell
16,400
-26,800
-62% -$330K ﹤0.01% 2421
2015
Q3
$415K Buy
43,200
+26,700
+162% +$390K 0.01% 1929
2015
Q2
$237K Sell
16,500
-119,500
-88% -$1.31M ﹤0.01% 2402
2015
Q1
$1.22M Buy
136,000
+89,600
+193% +$649K 0.02% 928
2014
Q4
$283K Buy
46,400
+26,300
+131% +$241K ﹤0.01% 2018
2014
Q3
$213K Buy
20,100
+14,300
+247% +$162K ﹤0.01% 2324
2014
Q2
$69K Sell
5,800
-24,500
-81% -$308K ﹤0.01% 3318
2014
Q1
$452K Sell
30,300
-28,200
-48% -$445K 0.01% 1716
2013
Q4
$858K Buy
58,500
+9,000
+18% +$138K 0.01% 1207
2013
Q3
$842K Buy
49,500
+22,700
+85% +$399K 0.02% 1142
2013
Q2
$445K Buy
+26,800
New +$434K 0.01% 1446

Other funds holding IMGN

Group One Trading's IMGN Position: Q4 2023 in Review

Group One Trading sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 238,327 shares — an estimated $4.75M sold.

Group One Trading first reported a position in IMGN in Q2 2013 and held it in 33 quarters. The position peaked at $3.78M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Group One Trading reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 238,327 Immunogen Inc shares in Q4 2023, an estimated $4.75M.
  • Group One Trading first reported a position in Immunogen Inc in Q2 2013 and held it in 33 quarters.
  • Group One Trading's Immunogen Inc position peaked at $3.78M in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.